Introduction
============

In dairy farms, mastitis is a persistent problem resulting in economic losses and premature culling of cows. *Staphylococcus aureus* (*S. aureus*) is considered a major causative pathogen which is a threat to farmers, although easily identifiable, whereas other gram negative bacteria is overlooked or not considered to be a cause for concern by farmers. Subclinical mastitis, which is defined as a somatic cell count (SCC) of \>200,000 cells/mL in milk, is usually caused by gram negative bacteria, such as *Escherichia coli* (*E. coli*), *Klebsiella pneumoniae*, and *Serratia marcescen*s ([@ref-33]; [@ref-3]). These bacteria are commonly found in environmental settings, such as bedding, clothes, farmers' hands, and water used on farms ([@ref-31]; [@ref-20]; [@ref-3]). Among gram negative bacteria, *E. coli* is the most notable cause of mastitis. *E. coli* was found to usually infected mammary gland of cows parturition and early lactation period which could lead to local and acute mastitis ([@ref-4]). In a study in Portugal, *E. coli* was found to be the second most common bacteria after non-coagulative staphylococci found in bulk tank milk ([@ref-3]). In Uruguay, *E. coli* was second only to *S. aureus* in bovine subclinical mastitis cases ([@ref-16]), whereas in China, it was one of the leading types of coliform bacteria found in milk from cows with subclinical mastitis ([@ref-25]; [@ref-39]).

The treatment of bovine subclinical mastitis usually depends on the severity of the symptoms. In Thailand, the disease is usually treated with antibiotics or the infected cows are culled. Antibiotics are also used for prevention in some farms. However, this can lead to bacteria developing resistance to them. For example, increased resistance to antibiotics in *S. aureus* in the form of oxacillin- or gentamicin-resistant strains was reported in Thailand due to their excessive use ([@ref-36]; [@ref-37]). Despite this background, there is little information on antibiotic resistance and drug resistance genes in other bacteria related to bovine mastitis in Thailand. *E. coli* can be antibiotic-resistant as it is also exposed to antibiotics from wastewater from farms. Furthermore, *E. coli* that carries resistance genes can transfer those genes to other pathogenic bacteria ([@ref-19]). The discovery of antibiotic resistance in *E. coli* isolates from farms could possibly show the trend or specific characteristic of antibiotic resistance and facilitate better prevention or the more effective treatment for mastitis on dairy farm. This study was thus conducted to detect *E. coli* from water sources and milk from cows with subclinical mastitis, and their antibiotic resistance patterns.

Materials and Methods
=====================

Sample collection
-----------------

All procedures performed in this study are in accordance with the ethical standards of the Faculty of Tropical Medicine--Animal Care and Use Committee (FTM-ACUC), Mahidol University, Thailand (protocol no. 002-2016). Water and milk samples were collected from 17 dairy farms in Saraburi Province, Thailand, where agriculture and livestock are the main source of income of the people. A total of 35 water samples were collected in 500-ml sterile bottles from drinking water for cows in a milking area and also from washing water. Thirty-eight milk samples were collected in sterile falcon tubes from cows with subclinical mastitis, which had an SCC of \>200,000 cells/ml in milk, after the teats had been disinfected with 70% ethanol and 4--5 streams of milk had been removed. Both water and milk samples were stored at 4 °C and transported to the laboratory within 24 h for the experiment.

Bacterial isolation
-------------------

Each water and milk sample was centrifuged at 6,000 rpm for 10 min, and the precipitant was subjected to 10-fold dilution and spread on MacConkey agar (Becton, Dickinson, and Company). Suspected *E. coli* lactose-fermenting colonies (pink colonies) were subjected to gram staining and standard biochemical tests, including triple sugar iron agar, lysine decarboxylase, ornithine decarboxylase/deaminase, motility, and indole production tests.

Antibiotic susceptibility tests
-------------------------------

All *E. coli* isolates were subjected to antibiotic susceptibility tests following the Clinical and Laboratory Standards Institute (CLSI) guidelines ([@ref-8]). The antimicrobial disks used in the experiment included 10 µg ampicillin (≤13 mm), 100 µg piperacillin (≤17 mm), 10 µg carbenicillin (≤17 mm), 20 µg amoxicillin-clavulanic acid (≤13 mm), 30 µg cefepime (≤14 mm), 30 µg cefotaxime (≤22 mm), 30 µg ceftriaxone (≤19 mm), 30 µg ceftazidime (≤17 mm), 75 µg cefoperazone (≤15 mm), 30 µg cefuroxime (≤14 mm), 10 µg imipenem (≤19 mm), 10 µg meropenem (≤19 mm), 10 µg gentamicin (≤12 mm), 30 µg amikacin (≤14 mm), 15 µg tigecycline (≤14 mm), 5 µg ciprofloxacin (≤15 mm), 10 µg norfloxacin (≤12 mm), and 23.75 µg trimethoprim--sulfamethoxazole (≤10 mm) (Oxoid). *E. coli* strain ATCC 25922 was used as a control in this experiment.

Extended spectrum β-lactamase (ESBL) production was tested by double disk synergy (DDS) method modified from [@ref-7]. The test uses 30 µg antibiotic disks of cefepime, cefotaxime ceftriaxone, ceftazidime, and cefuroxime. The antibiotic disks were placed on the *E. coli* spreaded MHA culture plate, 30 mm (center to center) from the amoxicillin-clavulanic acid (30 µg) disk. Plates were incubated at 37 °C overnight and observed for the presence of an extended spectrum beta-lactamase (ESBL) phenotype by an extension of the edge of inhibition zone of antibiotic disks toward the amoxicillin-clavulanic acid.

Gene detection by polymerase chain reaction
-------------------------------------------

All *E. coli* isolates from both water and milk samples were determined using specific gene and plasmid, and the isolates that showed resistance to antibiotics were selected and subjected to PCR to investigate their drug resistance genes. The bacteria were cultured in 1.5 ml of tryptic soy broth (Oxoid) and incubated overnight; they were then harvested and centrifuged for 10 min at 6,000 rpm. The pellet was resuspended with 800 µl of sterile distilled water, boiled for 10 min, centrifuged at 6,000 rpm for 10 min, and then the supernatant was collected for use as a DNA template in PCR. PCR primers, conditions, and positive control strains for the detection of target gene and drug resistance genes are presented in [Tables 1](#table-1){ref-type="table"} and [2](#table-2){ref-type="table"}. All PCR reactions with a total volume of 25 µl were performed in 1× Taq buffer, 1 mM MgCl~2~, 0.2 mM dNTP, 1 µM of each of the forward and reverse primers, and 2 units of *Taq* DNA polymerase (Thermo Scientific). The PCR amplicon was subjected to 1.5% agarose gel electrophoresis in TAE buffer. For gene amplification with no reference control, the PCR product from positive samples was subjected to nucleotide sequencing and sequence analysis for gene confirmation.
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###### Primers and PCR conditions used for virulence gene detection.
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  Target genes                                                               Positive control   Sequences (5′--3′)                                      Annealing temperature (°C)   Product size (bp)   References
  -------------------------------------------------------------------------- ------------------ ------------------------------------------------------- ---------------------------- ------------------- ------------
  Heat-labile toxin (*lt*)                                                   ETEC               tctctatgcatacggag ccatactgattgccgcaatt                  55                           322                 [@ref-10]
  Hest-stable toxin (*st*)                                                   ETEC               tgctaaaccagtagagtcttcaaaa gcaggcttacaacacaattcacagcag   55                           138                 [@ref-26]
  Shiga-like enterotoxins 1 (*evt*)                                          EHEC               caacactggatgatctcag ccccctcaactgctaata                  55                           349                 [@ref-21]
  Shiga-like enterotoxins 2 (*evs*)                                          EHEC               atcagtcgtcactcactggt ctgctgtcacagtgacaaa                55                           110                 [@ref-21]
  Transcriptional activator of the aggregative adherence fimbriae (*agg*R)   EAEC 17-2          ctaattgtacaatcgatgta atgaagtaattcttgaat                 55                           308                 [@ref-29]
  *pCVD*432 plasmid                                                          EAEC 17-2          ctggcgaaagactgtatcat caatgtatagaaatccgctgtt             55                           630                 [@ref-2]
  Intimin (*eae*A)                                                           Plasmid-*eae*A     aaacaggtgaaactgttgcc tctcgcctgatagtgtttggta             55                           350                 [@ref-40]
  Bundle-forming pilus (*bfp*A)                                              --                 aatggtgcttgcgcttgctgc gccgctttatccaacctggta             57                           326                 [@ref-41]

**Notes.**

ETECenterotoxigenic *E. coli*EHECenterohemorrhagic *E. coli*EAECenteroaggregative *E. coli*
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###### Primers and PCR conditions used for antibiotic resistance gene detection.
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  Drug resistance genes   Positive control   Sequences (5′--3′)                           Annealing temperature (°C)   Product size (bp)   References
  ----------------------- ------------------ -------------------------------------------- ---------------------------- ------------------- ------------
  ***Beta-lactams***                                                                                                                       
  *bla*~TEM~              --                 ttaactggcgaactacttac gtctatttcgttcatccata    60                           247                 [@ref-22]
  *bla*~SHV~              --                 aggattgactgccttttg atttgctgatttcgctcg        60                           393                 [@ref-22]
  *bla*~CMY-2~            --                 gacagcctctttctccaca tggacacgaaggctacgta      60                           1,000               [@ref-22]
  ***Aminoglycosides***                                                                                                                    
  *aac*(3)-IIa            --                 cggaaggcaataacggag tcgaacaggtagcactgag       60                           740                 [@ref-34]
  *aac*(3)-IV             --                 gtgtgctgctggtccacagc agttgacccagggctgtcgc    60                           627                 [@ref-24]
  *aad*A                  --                 cccctggagagagcgagatt cgtggctggctcgaagatac    60                           152                 Our study
  *aad*B                  --                 gaggagttggactatggatt cttcatcggcatagtaaaag    60                           208                 [@ref-22]
  ***Quinolone***                                                                                                                          
  *qnr*A                  --                 agaggatttctcacgccagg tgccaggcacagatcttgac    60                           580                 [@ref-5]
  *qnr*B                  --                 ggcattgaaattcgccactg tttgctgctcgccagtcgaa    60                           264                 [@ref-5]
  *qnr*S                  --                 gcaagttcattgaacagggt tctaaaccgtcgagttcggcg   60                           428                 [@ref-5]

Serotyping
----------

*E. coli* isolates with virulence genes were serotyped using Serosystem (Serosystem, Clinag, Thailand) to identify O and H antigens present on the surface of the pathogenic *E. coli* isolates with slide agglutination test. The experiment was performed following the manufacturer's protocol. EAEC, EHEC, EPEC, and ETEC strains were used as positive control in the experiment.

Results
=======

*E. coli* isolation and antibiotic resistance patterns
------------------------------------------------------

A total of 185 *E. coli* isolates were collected from water (116 isolates) and milk (69 isolates) samples and subjected to antibiotic susceptibility tests. Among these isolates, a total of 77 (51 isolates from water and 26 isolates from milk samples) showed resistance to at least one of the antibiotics use in the experiment. Penicillin-resistant *E. coli* (71/77, 92.2%) was found to be the largest group in this study followed by folate pathway inhibitor-resistant *E. coli* (20/77, 26%). *E. coli* resistant to cephems (14/77, 18.2%), aminoglycosides (14/77, 18.2%), *β*-lactamase inhibitor combination (4/77, 5.2%), fluoroquinolone (12/77, 14.3%), and carbapenem (1/77, 1.3%) were also found. Among antibiotic resistant *E. coli*, 84.31% (43/51) of *E. coli* found in water samples are multidrug resistance and 84.61% (22/26) in milk samples ([Table 3](#table-3){ref-type="table"}). The antibiotic patterns could be divided into 21 types, as shown in [Table 3](#table-3){ref-type="table"}. We also found the ESBL phenotype (12/185, 6.5%) in six *E. coli* isolates each from water and milk samples. The antibiotics that the *E. coli* strains are susceptible to are as shown in [Fig. 1](#fig-1){ref-type="fig"}.
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###### Distribution of antibiotic resistance phenotypic patterns of *E. coli* isolates.
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  Resistance pattern   Phenotypic resistance                        Number of resistant *E. coli* isolates   
  -------------------- -------------------------------------------- ---------------------------------------- -----------
  I                    AMC                                          1 (1.9%)                                 0 (0%)
  II                   AMC, AMP, CAR                                2 (3.9%)                                 0 (0%)
  III                  AMC, AMP, CAR, IPM                           1 (1.9%)                                 0 (0%)
  IV                   AMP                                          3 (5.8%)                                 2 (7.6%)
  V                    AMP, CAR                                     26 (50.9%)                               0 (0%)
  VI                   AMP, CAR, CAZ, CN, CRO, CTX, CXM             2 (3.9%)                                 0 (0%)
  VII                  AMP, CAR, CAZ, CN, CRO, CTX, CXM, FEP        0 (0%)                                   6 (23.0%)
  VIII                 AMP, CAR, CAZ, CN, CRO, CTX, CXM, FEP, SCF   0 (0%)                                   1 (3.8%)
  IX                   AMP, CAR, CAZ, CN, CRO, CTX, CXM, FEP, SXT   1 (1.9%)                                 0 (0%)
  X                    AMP, CAR, CAZ, CN, CRO, CTX, CXM, SXT        1 (1.9%)                                 0 (0%)
  XI                   AMP, CAR, CIP, CN, CRO, CTX, CXM, FEP, SXT   1 (1.9%)                                 0 (0%)
  XII                  AMP, CAR, CIP, NOR                           0 (0%)                                   7 (26.9%)
  XIII                 AMP, CAR, CIP, NOR, SXT                      1 (1.9%)                                 0 (0%)
  XIV                  AMP, CAR, CN, CRO, CTX, CXM, SXT             1 (1.9%)                                 0 (0%)
  XV                   AMP, CAR, NOR                                1 (1.9%)                                 0 (0%)
  XVI                  AMP, CAR, SXT                                6 (11.7%)                                7 (26.9%)
  XVII                 AMP, CAZ, CRO, CTX, CXM                      0 (0%)                                   1 (3.8%)
  XVIII                CN                                           1 (1.9%)                                 0 (0%)
  XIX                  NOR                                          1 (1.9%)                                 1 (3.8%)
  XX                   SXT                                          1 (1.9%)                                 1 (3.8%)
  XXI                  TZP                                          1 (1.9%)                                 0 (0%)

**Notes.**

AMPampicillinTZPpiperacillinCARcarbenicillinAMCamoxicillin--clavulanic acidFEPcefepimeCTXcefotaximeCROceftriaxoneCAZceftazidimeSCFcefoperazoneCXMcefuroximeIPMimipenemMEMmeropenemCNgentamicinAKamikacinTGCtigecyclineCIPciprofloxacinNORnorfloxacinSXTtrimethoprim--sulfamethoxazole

Specific gene and drug resistance gene detection and serotyping
---------------------------------------------------------------

All 185 *E. coli* isolates from both water and milk samples were also subjected to an analysis of the virulence genes and plasmid for EAEC, EHEC, EPEC, and ETEC (*agg* R and *pCVD*432, *evt* and *evs*, *eae*A and *bfp*A, and *lt* and *st*, [Fig. 2](#fig-2){ref-type="fig"}). Among the bacterial isolates, 24 (24/185, 12.97%) showed positive results for gene detection by PCR, with *bfp*A positive isolates, EPEC forming the majority (13/185, 7.02%) followed by *pCVD*432 positive isolates, EAEC (8/185, 4.32%) and *evt* positive isolates, EHEC (3/185, 1.62%) ([Fig. 3](#fig-3){ref-type="fig"}). All EPEC *E. coli* isolates were from water samples. Among them, the bacteria presented different serotypes, namely, O124:K62 (2/13, 15.4%), O111:K58 (2/13, 15.4%), O128:K67 (1/13, 7.7%), O78:K80 (1/13, 7.7%), and O86:K61 (1/13, 7.7%). EAEC isolated from milk samples possessed the O18aO18C:K77 serotype (6/8, 75%) and those from water samples possessed the O112aO112c:K66 serotype (1/8, 12.5%), whereas one isolate could not be serotyped. EHEC isolates from milk samples possessed the O114:K serotype (2/3, 66.7%), whereas positive isolates from water could not be serotyped ([Table 4](#table-4){ref-type="table"}).

The bacterial antibiotic-resistant isolates (77 isolates) were investigated for drug resistance genes (*β*-lactam: *bla*~TEM~, *bla*~SHV~, *bla*~CMY-2~; aminoglycoside: *aac*(3)-IIa, *aac*(3)-IV, *aad*A, *aad*B; quinolone: *qnr*A, *qnr*B, and *qnr*S) using PCR. The results showed that one *pCVD*432 positive *E. coli* and one *bfpA* positive *E. coli* isolates possessed *bla*~CMY-2~ and *bla*~TEM~, respectively. We also found one *pCVD*432 positive isolate with the ESBL phenotype that carried both *bla*~TEM~ and *bla*~CMY-2~. In non-pathogenic *E. coli* isolates, 43 (43/77, 55.9%) isolates were found to possess various antibiotic resistance genes ([Table 5](#table-5){ref-type="table"}). The most common resistant gene found was *bla*~TEM~ (38/62, 61.3%) followed by *bla*~CMY-2~ (16/62, 25.8%) and *aac*(3)IIa (3/62, 4.9%). Other resistance genes carried by non-pathogenic isolates were *aad*A (2/62, 3.3%) and *bla*~SHV~(2/62, 3.3%). None of the *E. coli* isolates carried quinolone resistance genes.

![Antibiotic susceptibility test results.\
(A) *E. coli* isolates from water samples. (B) *E. coli* isolates from milk samples.](peerj-05-3431-g001){#fig-1}

![Agarose gel electrophoresis of 1% agarose of the amplification products of virulence genes and plasmid for ETEC (*lt, st*), EHEC (*evt, evs*), EAEC (*pCVD*432, *agg*R), and EPEC (*eae*A, *bfp*A).\
M, DNA Marker.](peerj-05-3431-g002){#fig-2}

![Prevalence of pathogenic *E. coli* detected from water and milk samples.](peerj-05-3431-g003){#fig-3}
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###### Target genes, serotyping, antibiotic resistance pattern, resistant gene profile, and ESBL phenotype of pathogenic *E. coli* isolates.
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  Isolate number   Origin   Target gene   Serotype                            Antibiotic resistance pattern        Resistance gene profile                         ESBL phenotype
  ---------------- -------- ------------- ----------------------------------- ------------------------------------ ----------------------------------------------- -----------------------------------
  M-W910-1 LF1     Water    *bfp*A        [^a^](#table-4fn1){ref-type="fn"}   [^\*^](#table-4fn2){ref-type="fn"}   −                                               −
  M-W910-1 LF3     Water    *bfp*A        [^a^](#table-4fn1){ref-type="fn"}   [^\*^](#table-4fn2){ref-type="fn"}   [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-W1010-1 LF1    Water    *bfp*A        [^a^](#table-4fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-4fn4){ref-type="fn"}
  M-W1110-1 LF3    Water    *bfp*A        [^a^](#table-4fn1){ref-type="fn"}   XX                                   [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-W1110-1 LF5    Water    *bfp*A        O124:K62                            [^\*^](#table-4fn2){ref-type="fn"}   [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-W1110-1 LF6    Water    *bfp*A        O111:K58                            [^\*^](#table-4fn2){ref-type="fn"}   [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-W12UD LFB6     Water    *bfp*A        O111:K58                            I                                    [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-W13UD LFB6     Water    *bfp*A        O128:K67                            [^\*^](#table-4fn2){ref-type="fn"}   [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-W13UD LFB7     Water    *bfp*A        O124:K62                            [^\*^](#table-4fn2){ref-type="fn"}   [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-W13UD LFB10    Water    *bfp*A        O78:K80                             [^\*^](#table-4fn2){ref-type="fn"}   [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-W15UD LFB4     Water    *bfp*A        [^a^](#table-4fn1){ref-type="fn"}   V                                    [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-W22UD LF9      Water    *pCVD*432     [^a^](#table-4fn1){ref-type="fn"}   VI                                   *bla*~CMY-2~, *aac*(3)IIa                       [^−^](#table-4fn4){ref-type="fn"}
  M-W23UD LF2      Water    *pCVD*432     O112aO112c:K66                      VI                                   *bla*~TEM~, *bla*~CMY-2~, *aac*(3)IIa*, aad*A   [^+^](#table-4fn3){ref-type="fn"}
  M-W32UD LF1      Water    *bfp*A        [^a^](#table-4fn1){ref-type="fn"}   V                                    [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-W33UD LF1      Water    *bfp*A        O86:K61                             [^\*^](#table-4fn2){ref-type="fn"}   [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-M10UD LFB4     Milk     *evt*         O114:K                              [^\*^](#table-4fn2){ref-type="fn"}   [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-M10UD LFB5     Milk     *evt*         O114:K                              [^\*^](#table-4fn2){ref-type="fn"}   [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}
  M-M35UD LFB2     Milk     *pCVD*432     O18aO18c:K77                        VII                                  [^−^](#table-4fn4){ref-type="fn"}               [^+^](#table-4fn3){ref-type="fn"}
  M-M35UD LFB3     Milk     *pCVD*432     O18aO18c:K77                        VII                                  [^−^](#table-4fn4){ref-type="fn"}               [^+^](#table-4fn3){ref-type="fn"}
  M-M35UD LFB4     Milk     *pCVD*432     O18aO18c:K77                        VII                                  [^−^](#table-4fn4){ref-type="fn"}               [^+^](#table-4fn3){ref-type="fn"}
  M-M35UD LFB5     Milk     *pCVD*432     O18aO18c:K77                        VIII                                 [^−^](#table-4fn4){ref-type="fn"}               [^+^](#table-4fn3){ref-type="fn"}
  M-M35UD LFB6     Milk     *pCVD*432     O18aO18c:K77                        VII                                  [^−^](#table-4fn4){ref-type="fn"}               [^+^](#table-4fn3){ref-type="fn"}
  M-M35UD LFB7     Milk     *pCVD*432     O18aO18c:K77                        VII                                  [^−^](#table-4fn4){ref-type="fn"}               [^+^](#table-4fn3){ref-type="fn"}
  M-M37UD LFB4     Milk     *evt*         [^a^](#table-4fn1){ref-type="fn"}   XVI                                  [^−^](#table-4fn4){ref-type="fn"}               [^−^](#table-4fn4){ref-type="fn"}

**Notes.**

Not typable.

Susceptible.

Positive.

Negative.
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###### Target genes, serotyping, antibiotic resistance pattern, resistant gene profile, and ESBL phenotype of non-pathogenic *E. coli* isolates.
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  Isolate number   Origin   Target gene                         Serotype                            Antibiotic resistance pattern        Resistance gene profile                         ESBL phenotype
  ---------------- -------- ----------------------------------- ----------------------------------- ------------------------------------ ----------------------------------------------- -----------------------------------
  M-W610-1 LF1     Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W910-1 LF2     Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   IV                                   *bla*~CMY-2~                                    [^−^](#table-5fn4){ref-type="fn"}
  M-W1110-1 LF9    Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XVI                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W12UD LFB6     Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   I                                    *bla*~CMY-2~                                    [^−^](#table-5fn4){ref-type="fn"}
  M-W16UD LF1      Water                                        [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~, *bla*~SHY~, *bla*~CMY-2~            [^−^](#table-5fn4){ref-type="fn"}
  M-W16UD LF2      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~, *bla*~CMY-2~                        [^−^](#table-5fn4){ref-type="fn"}
  M-W1910-1 LF6    Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W20UD LF6      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~, *bla*~CMY-2~                        [^−^](#table-5fn4){ref-type="fn"}
  M-W20UD LF9      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~, *bla*~CMY-2~                        [^−^](#table-5fn4){ref-type="fn"}
  M-W22UD LF3      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XIV                                  *bla*~TEM~, *bla*~CMY-2~                        [^+^](#table-5fn3){ref-type="fn"}
  M-W22UD LF7      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   X                                    *bla*~TEM~, *bla*~CMY-2~, *aac*(3)IIa           [^+^](#table-5fn3){ref-type="fn"}
  M-W24UD LF1      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W24UD LF3      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XI                                   *bla*~TEM~, *bla*~CMY-2~, *aac*(3)IIa, *aad*A   [^+^](#table-5fn3){ref-type="fn"}
  M-W24UD LF4      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W24UD LF5      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XVI                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W24UD LF7      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   [^\*^](#table-5fn2){ref-type="fn"}   *bla*~TEM~, *bla*~CMY-2~                        [^−^](#table-5fn4){ref-type="fn"}
  M-W26UD LF8      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   IV                                   *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W27UD LF4      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XVI                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W28UD LF1      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XV                                   *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W28UD LF5      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~SHV~, *bla*~CMY-2~                        [^−^](#table-5fn4){ref-type="fn"}
  M-W28UD LF7      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~, *bla*~CMY-2~                        [^−^](#table-5fn4){ref-type="fn"}
  M-W29UD LF1      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   IX                                   *bla*~TEM~, *bla*~CMY-2~, *aac*(3)IIa, *aad*A   [^+^](#table-5fn3){ref-type="fn"}
  M-W29UD LF10     Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XVI                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W31UD LF6      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W33UD LF2      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W33UD LF6      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W33UD LF9      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W33UD LF10     Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W34UD LF3      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   V                                    *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-W34UD LF7      Water    [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XIII                                 *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-M1610-1 LFB2   Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   IV                                   *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-M37UD LFB1     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XVI                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-M37UD LFB3     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XVI                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-M37UD LFB5     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XVI                                  *bla*~CMY-2~                                    [^−^](#table-5fn4){ref-type="fn"}
  M-M37UD LFB6     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XVI                                  *bla*~TEM~, *bla*~CMY-2~                        [^−^](#table-5fn4){ref-type="fn"}
  M-M37UD LFB8     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XVI                                  *bla*~CMY-2~                                    [^−^](#table-5fn4){ref-type="fn"}
  M-M38UD LFB1     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XII                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-M38UD LFB2     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XII                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-M38UD LFB3     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XII                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-M38UD LFB4     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XII                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-M38UD LFS2     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XII                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-M38UD LFS3     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XII                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}
  M-M38UD LFS4     Milk     [^−^](#table-5fn4){ref-type="fn"}   [^b^](#table-5fn1){ref-type="fn"}   XII                                  *bla*~TEM~                                      [^−^](#table-5fn4){ref-type="fn"}

**Notes.**

Not serotype.

Susceptible.

Positive.

Negative.

Discussion
==========

*E. coli* is known to be the most common gram negative bacteria that potentially causes subclinical mastitis and exhibits antibiotic resistance. However, pathogenic *E. coli* in the environment has often been overlooked. Many studies have reported the presence of *E. coli* among subclinical mastitis cases in dairy farms in many regions of the world, particularly in developing countries, such as Uruguay, Turkey, Brazil, Ethiopia, Mexico, and China ([@ref-16]; [@ref-17]; [@ref-12]; [@ref-18]; [@ref-1]; [@ref-30]; [@ref-39]). This study demonstrated the existence of pathogenic *E. coli* in environmental sources and also in milk from cows with subclinical mastitis by detecting specific genes associated with the pathogenic types of this species. *bfp*A-positive *E. coli* was found to be the most common strain of pathogenic *E. coli* residing in water sources. *pCVD*432-positive isolate was found in both water and milk samples. *evt-*positive *E. coli* was the least common and was only identified in milk samples; it was not present in any of the water samples. In this study, EPEC possessed only *bfp*A, which encodes bundle-forming pili that are a specific characteristic of EPEC ([@ref-6]). The presence of EPEC in water sources in dairy farms could lead to intramammary infection of cows. A study by [@ref-11] also reported the isolation of *bfp*A-positive EPEC from persistent cases of bovine mastitis ([@ref-11]). Although none of the *E. coli* isolates was positive for *eae*A in this study, there are reports of the presence of *eae*A-positive EPEC among *E. coli* found in cows with mastitis in Brazil and Turkey ([@ref-9]; [@ref-17]). However, in Iran, *eae*A-positive *E. coli* was not found in clinical mastitis cases ([@ref-15]). This indicates that *bfp*A- and *eae*A-positive EPEC may be distributed unevenly across the globe. EAEC (*pCVD*432-positive isolates) was found in both water and milk samples. However, the serotypes of those isolates differed. This may indicated different sources of EAEC in water and infected cows. The results also designated that EAEC may be an epidemic strain in dairy farms in Saraburi Province, and EAEC and EPEC could be causative agents of mastitis considering their potential infection through water in farms. EHEC was the least common group found only in milk samples in this study and positive only for *evt* (shiga-toxin 1-encoding gene). These results raise concerns regarding the bacterial distribution to nearby areas via the contaminated water which workers should be aware of. Studies by [@ref-23] and [@ref-27] also reported shiga-toxin 1-producing *E. coli* from cases of subclinical mastitis in cows in Brazil and Iran. [@ref-28] later reported that shiga-toxin 1-producing *E. coli* was the most common type of *E. coli* in milk samples from cows with subclinical mastitis in Iran ([@ref-28]). These results also correlated with many studies on clinical cases of bovine mastitis. For example, [@ref-28] reported the presence of EHEC with shiga-toxin 1-encoding gene as the most common virulence gene in milk samples from cases with subclinical and clinical mastitis ([@ref-28]), which also correlated with the study by [@ref-35], in which shiga-toxin 1-encoding gene was among the most common virulence genes found in clinical cases of bovine mastitis ([@ref-35]).

Among the 21 antibiotic resistance patterns, the most common pattern found in *E. coli* from water sources was pattern V (ampicillin and carbenicillin resistance), followed by pattern XVI (ampicillin, carbenicillin, gentamicin, ceftriaxone, cefotaxime, and trimethoprim/sulfamethoxazole resistance). Among the antibiotic patterns in the *E. coli* from milk, pattern XII (ampicillin, carbenicillin, ciprofloxacin, and norfloxacin resistance) and XVI were the most common. This may indicate that *E. coli* in milk could potentially derive from water or other environmental sources. A study by [@ref-32] also reported the difference in antibiotic resistance patterns between *E. coli* isolated from farm water and fecal samples ([@ref-32]). Our results call for a more cautious approach with antibiotics usage in dairy farms in the Saraburi province area, since the antibiotics that the *E. coli* isolates were susceptible to are from the high generation cephalosporin and *β*-lactam classes which are normally used for the treatment of drug-resistance bacteria.

In another study, [@ref-14] reported on ESBL-positive *E. coli* in milk from cows with mastitis [@ref-14], and ESBL-producing *E. coli* was shown to be able to spread from infected animals to the environment, such as air and slurry, as reported in a pig farm in Germany ([@ref-38]). In this study, EAEC was the only pathogenic strain that possessed the ESBL phenotype. Notably, only the ESBL-producing EAEC isolates from water samples contained antibiotic resistance genes (*bla*~TEM~ and *bla*~CMY-2~). The results also correlate with the study by [@ref-13], who reported that EAEC found in surface water and wastewater dominates over other strains of pathogenic *E. coli* in terms of possessing the ESBL phenotype ([@ref-13]). In this study, we found that non-pathogenic *E. coli* isolates carried ESBL-associated genes (*bla*~TEM~, *bla*~SHV~, and *bla*~CMY-2~. However, only four isolates (M-W22UD LF3, M-W22UD LF7, M-W24UD LF3, and M-W29UD LF1) presented the ESBL phenotype and all of these carried *bla*~TEM~ and *bla*~CMY-2~. These results imply that the presence of drug-resistant strains of non-pathogenic *E. coli* isolates from the environment is possible. This can pose a threat to mastitis management programs for farm since one study also reported that non-pathogenic *E. coli* can serve as a reservoir of antibiotic resistance genes and could possibly transfer the genes to other pathogenic *E. coli* if conditions are suitable ([@ref-19]).

Conclusion
==========

This study provides evidence that *E. coli* isolates from cows with subclinical mastitis and from water at dairy farms in Saraburi Province of Thailand consisted of pathogenic *E. coli* strains that are resistant to many groups of antibiotics, including the fluoroquinolone group, which should raise concerns regarding the improper use of antibiotics in this area. However, the information on which antibiotics are being used on the farms is very limited. Identification of the ESBL phenotype and *β*-lactamase genes was also a concern as these can be transferred to other *E. coli* strains, including pathogenic strains, and bacterial species. This could lead to more serious problems associated with antibiotic resistance in the future. It should be recommended that farms prevent mastitis by promote clean environments for cows such as frequently changing bedding at the stalls and milking areas by cleaning the areas thoroughly. The use of dry and clean cloths to clean the teats before milking and effective teat dips should reduce mastitis on farms. The use of antibiotics, mastitis control programs, and milking hygiene should be considered and supervised by veterinarians to improve mastitis status and treatment in this area.
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